Similar articles for PMID: 25471070

Year	Number of Results
2008	3
2009	3
2010	2
2011	3
2012	6
2013	9
2014	15
2015	30
2016	24
2017	33
2018	32
2019	32
2020	17
2021	18
2022	17
2023	15
2024	10
2025	0

1

Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.

Leonard J, Baker DE. Leonard J, et al. Ann Pharmacother. 2015 Mar;49(3):360-5. doi: 10.1177/1060028014560191. Epub 2014 Dec 3. Ann Pharmacother. 2015. PMID: 25471070 Review.

2

Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.

Webster L, Diva U, Tummala R, Sostek M. Webster L, et al. Pain Pract. 2018 Apr;18(4):505-514. doi: 10.1111/papr.12640. Epub 2017 Nov 27. Pain Pract. 2018. PMID: 28898536 Clinical Trial.

3

Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced Constipation.

Al-Huniti N, Nielsen JC, Hutmacher MM, Lappalainen J, Cantagallo K, Sostek M. Al-Huniti N, et al. CPT Pharmacometrics Syst Pharmacol. 2016 Jul;5(7):359-66. doi: 10.1002/psp4.12099. Epub 2016 Jul 20. CPT Pharmacometrics Syst Pharmacol. 2016. PMID: 27435972 Free PMC article.

4

Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.

Lawson R, Ryan J, King F, Goh JW, Tichy E, Marsh K. Lawson R, et al. Pharmacoeconomics. 2017 Feb;35(2):225-235. doi: 10.1007/s40273-016-0454-4. Pharmacoeconomics. 2017. PMID: 27663572

5

Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.

Lawson R, King F, Marsh K, Altincatal A, Cimen A. Lawson R, et al. Adv Ther. 2016 Aug;33(8):1331-46. doi: 10.1007/s12325-016-0365-y. Epub 2016 Jun 24. Adv Ther. 2016. PMID: 27342744 Free PMC article. Clinical Trial.

6

Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.

Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M. Webster L, et al. Aliment Pharmacol Ther. 2014 Oct;40(7):771-9. doi: 10.1111/apt.12899. Epub 2014 Aug 12. Aliment Pharmacol Ther. 2014. PMID: 25112584 Free article. Clinical Trial.

7

Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.

White WB, Kowey P, Diva U, Sostek M, Tummala R. White WB, et al. J Cardiovasc Pharmacol Ther. 2018 Jul;23(4):309-317. doi: 10.1177/1074248418760239. Epub 2018 Mar 4. J Cardiovasc Pharmacol Ther. 2018. PMID: 29504415

8

Naloxegol for the treatment of opioid-induced constipation.

Tack J, Corsetti M. Tack J, et al. Expert Rev Gastroenterol Hepatol. 2014 Nov;8(8):855-61. doi: 10.1586/17474124.2014.939629. Epub 2014 Sep 15. Expert Rev Gastroenterol Hepatol. 2014. PMID: 25220391 Review.

9

Naloxegol: a review of its use in patients with opioid-induced constipation.

Garnock-Jones KP. Garnock-Jones KP. Drugs. 2015 Mar;75(4):419-25. doi: 10.1007/s40265-015-0357-2. Drugs. 2015. PMID: 25666542 Review.

10

A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation.

Webster L, Tummala R, Diva U, Lappalainen J. Webster L, et al. J Opioid Manag. 2016 Nov/Dec;12(6):405-419. doi: 10.5055/jom.2016.0360. J Opioid Manag. 2016. PMID: 28059433 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 25471070

228 results

Results by year